Glucocorticoid-driven gene expression in circulating monocytes and neutrophils in health and severe inflammation

Arthur Molendijk1, Leo Koenderman2

  • 1Center for Translational Immunology, University Medical Center Utrecht, Utrecht University, Heidelberglaan 100, Utrecht 3584 CX, the Netherlands.

Insights

Glucocorticoids (GCs) impact immune cells differently depending on inflammation. This study identifies two gene signatures (GC-1 and GC-2) to monitor GC effects in blood, aiding treatment decisions.

Area of Science:

  • Immunology
  • Genomics
  • Pharmacology

Background:

  • Glucocorticoids (GCs) are widely used anti-inflammatory and immunosuppressive drugs.
  • Their efficacy and safety in sepsis and shock remain controversial due to limited understanding of cellular responses and gene regulation in vivo.
  • Identifying specific GC-regulated genes and cell types is crucial for optimizing their use.

Purpose of the Study:

  • To identify robust gene expression signatures of glucocorticoid (GC) induction in vivo.
  • To characterize GC-regulated genes and responding cell types in both healthy and inflamed states.
  • To develop transcriptomic biomarker gene sets for monitoring GC action.

Main Methods:

  • Analysis of large public blood transcriptomic datasets.
  • Utilized query genes related to GC induction under varying inflammatory conditions.
  • Developed gene expression correlation signatures (GC signature 1 and GC signature 2).
  • Compared whole blood signatures with tissue-specific and cell-specific datasets (monocytes, neutrophils).

Main Results:

  • Identified two distinct GC-induced gene expression signatures: GC signature 1 (circadian cortisol, NK cells, neutrophils) and GC signature 2 (severe inflammation, monocytes, neutrophils).
  • Found significant overlap between upregulated genes in GC-treated septic and burn shock patients and the derived GC signatures, suggesting direct GC regulation.
  • Established GC signatures in various tissues and isolated monocytes/neutrophils, providing a broader framework of GC effects in health and inflammation.

Conclusions:

  • GCs exert distinct regulatory effects on different blood cell types, varying with inflammatory status.
  • Developed two whole blood transcriptomic biomarker gene sets (GC-1 and GC-2) for monitoring cortisol action in health and severe inflammation, respectively.
  • These signatures offer valuable tools for understanding GC mechanisms and guiding clinical applications in immune-mediated diseases and critical illness.

Related Concept Videos

Chronic Inflammation: Introduction01:12

Chronic Inflammation: Introduction

Chronic inflammation is a prolonged, dysregulated immune response that persists for weeks to years when the inciting stimulus is difficult to eradicate or when self‑antigens drive ongoing reactivity. Morphologically, it is defined by mononuclear cell infiltration, progressive tissue destruction, and concurrent attempts at healing via angiogenesis and fibrosis. Compared with acute inflammation, edema is less prominent while cellular infiltration predominates; triggers include persistent...
Differentiation of Common Myeloid Progenitor Cells01:15

Differentiation of Common Myeloid Progenitor Cells

Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
Inflammatory Response I: Vascular and Cellular01:30

Inflammatory Response I: Vascular and Cellular

The inflammatory response is the body's defense against infection, injury, or irritation from bacteria, trauma, toxins, or heat. Inflammation helps locate and destroy pathogens and remove damaged tissue elements to heal the body. During this initial phase, fluid, blood products, and nutrients migrate to the injured area, resulting in redness, heat, swelling, ache, and loss of function. Moreover, signs of systemic inflammation include fever, increased WBC count, malaise, anorexia, nausea,...
Acute Inflammation III: Local and Systemic Effects01:25

Acute Inflammation III: Local and Systemic Effects

Acute inflammation produces a coordinated set of local and systemic changes that limit injury, eliminate pathogens, and initiate repair. These responses arise within minutes of infection, trauma, or chemical insult and are driven by vascular alterations and leukocyte-derived mediators. When the stimulus resolves, the reaction typically abates within days.Local EffectsAt the site of injury, arteriolar vasodilation increases blood flow, resulting in redness and warmth. Simultaneously, increased...
Acute Inflammation II: Cellular Phase01:26

Acute Inflammation II: Cellular Phase

The cellular phase of acute inflammation is a tightly orchestrated sequence of events that recruits leukocytes, primarily neutrophils, to sites of tissue injury or infection. Following the initial vascular changes, this phase ensures effective immune cell migration, activation, and function at the affected site to eliminate pathogens and initiate tissue repair.Leukocyte Recruitment CascadeLeukocyte recruitment happens in four steps: margination, adhesion, transmigration, and chemotaxis. Reduced...
Inflammatory Response01:28

Inflammatory Response

An inflammatory response is a localized, nonspecific immune reaction that occurs when a tissue is injured. It is characterized by redness, swelling, heat, and pain, which are commonly called the cardinal signs and symptoms of inflammation. Inflammation can sometimes result in a loss of function.
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...